DataMeds AI, Inc. (MEDS) stock
MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.64−0.00 (-0.28%)
Close on Nov 17, 2026Market cap $1.96MP/E –Yield –
DataMeds AI r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for DataMeds AI
DataMeds AI has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?